Curtis Lockshin

Insider Reports History

Location
Miami, FL
Signature
/s/ Lisa C. Carson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Curtis Lockshin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Phio Pharmaceuticals Corp. Director Common Stock, $.0001 par value 35,155 $35,858 $1.02 05 Feb 2026 Direct
Xenetic Biosciences, Inc. Chief Sciencific Officer Stock Options 10,000 11 Dec 2023 Direct

Insider Reports Filed by Curtis Lockshin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PHIO Phio Pharmaceuticals Corp. 05 Feb 2026 1 $0 4 Director 06 Feb 2026, 08:01
PHIO Phio Pharmaceuticals Corp. 11 Sep 2025 1 $0 4 Director 15 Sep 2025, 08:29
PHIO Phio Pharmaceuticals Corp. 11 Sep 2024 1 $0 4 Director 12 Sep 2024, 16:11
XBIO Xenetic Biosciences, Inc. 11 Dec 2023 1 $0 4 Chief Sciencific Officer 13 Dec 2023, 17:30
PHIO Phio Pharmaceuticals Corp. 17 Feb 2023 1 $0 4 Director 22 Feb 2023, 18:30
XBIO Xenetic Biosciences, Inc. 24 Mar 2022 1 $0 4 Chief Sciencific Officer 28 Mar 2022, 17:13
PHIO Phio Pharmaceuticals Corp. 15 Feb 2022 1 $0 4 Director 16 Feb 2022, 19:12
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .